COMMUNICATION:
Massive Actin Polymerization Induced by Phosphatidylinositol-4-phosphate 5-Kinase in Vivo*

(Received for publication, December 11, 1996, and in revised form, January 28, 1997)

Yoshikazu Shibasaki , Hisamitsu Ishihara , Nobuaki Kizuki , Tomoichiro Asano , Yoshitomo Oka § and Yoshio Yazaki

From the Third Department of Internal Medicine, University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113, Japan and the § Third Department of Internal Medicine, Yamaguchi University School of Medicine, Kogushi, Ube, Yamaguchi 755, Japan

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES


ABSTRACT

The Rho family GTP-binding proteins have been known to mediate extracellular signals to the actin cytoskeleton. Although several Rho interacting proteins have been found, downstream signals have yet to be determined. Many actin-binding proteins are known to be regulated by phosphatidylinositol 4,5-bisphosphate in vitro. Rho has been shown to enhance the activity of phosphatidylinositol-4-phosphate 5-kinase (PI4P5K), the phosphatidylinositol 4,5-bisphosphate synthesizing enzyme. Recently we isolated several isoforms of type I PI4P5K. Here we report that PI4P5K Ialpha induces massive actin polymerization resembling "pine needles" in COS-7 cells in vivo. When truncated from the C terminus to amino acid 308 of PI4P5K Ialpha , both kinase activity and actin polymerizing activity were lost. Although the dominant negative form of Rho, RhoN19, alone decreased actin fibers, those induced by PI4P5K were not affected by the coexpression of RhoN19. These results suggest that PI4P5K is located downstream from Rho and mediates signals for actin polymerization through its phosphatidylinositol-4-phosphate 5-kinase activity.


INTRODUCTION

The stimulation of cells by growth factors and other agonists is mediated by intracellular signal transduction pathways. In response to environmental signals, a cell changes both its shape and its degree of attachment to the substratum. These changes are caused, at least in part, by the polymerization and rearrangement of the actin into sheet-like structures known as lamellipodia and bundle-like stress fibers (1, 5). The Rho family GTP-binding proteins (Cdc42, Rac, and Rho) play key roles in transmitting signals to the cytoskeleton (1, 6, 7). They share a similar mode of action in that they cycle between the GTP-bound active and GDP-bound inactive form. Whereas constitutively active Rac induces lamellipodia, Rho induces stress fibers (5). When the dominant negative form of each protein is introduced, specific morphological change is blocked (1, 5). Downstream elements of the Rho signaling pathway to the cytoskeleton are not well defined, although several candidates have been reported including Rho GTPase-activating protein (1), protein kinase N (8, 9), Rho kinase (10, 11), and PtdIns4P1 5-kinase (7). Some of these interact with the GTP-bound active form of Rho; therefore they are good candidates for Rho effectors. However, because downstream signaling from Rho is not only involved in cytoskeletal organization but takes diverse pathways including gene transcription, it is not clear which molecule(s) is responsible for cytoskeletal changes.

Actin polymerization is dependent both on the availability of free barbed ends and that of monomeric G-actin, which are regulated by multiple actin-binding proteins (ABPs). Capping proteins bind to barbed ends to mask them, and monomer-binding proteins bind G-actins to sequester them. Several ABPs can bind PIP2 and release the free barbed end or free G-actin to polymerize (2). PIP2 is synthesized by PI4P5K, and Rho has been known to stimulate PI4P5K activity (3). Therefore PI4P5K is a suitable link between the Rho family and actin polymerization. Mammalian type 2 PI4P5K has been cloned (12). We recently cloned several isoforms of type I PI4P5K (4). Here we report its important role in actin polymerization in vivo.


MATERIALS AND METHODS

DNA Constructs

The wild type PI4P5K Ialpha construct with hemagglutinin (HA) epitope used was described previously (4). C-terminal deletion mutants were constructed by appropriate endonuclease digestion (BamHI and NcoI), designated 5K456S and 5K308M, and subcloning into the pAdex1CA vector (13). C-terminal sequences were confirmed by DNA sequencing. The amino acids of constructs are: WT, 1-539; 5K456S, 1-456 with extra Asn; and 5K308M, 1-308 with extra KLIKLV due to the polylinker sequence of the vector. Partial OCRL cDNA was isolated by polymerase chain reaction using primers corresponding to nucleotides 806-828 (sense) and the complement of nucleotides 1530-1550 (antisense) based on the published sequence and tagged with HA (14). The RhoN19 cDNA (threonine at codon 19 of Rho A was replaced with asparagine) was constructed by polymerase chain reaction, tagged with the Myc epitope at their N terminus and cloned into the pAdex1CA vector.

Adenovirus Infection, Western Blotting, and PtdIns4P 5-kinase Assay

Recombinant adenovirus methods and these techniques were the same as described previously (4, 13). Antibodies used were 12CA5 (anti-HA), 9E10 (anti-Myc), and 4G10 (anti-phosphotyrosine).

Immunofluorescence

COS-7 cells were maintained in Dulbecco's modified Eagle's medium with 10% fetal bovine serum. Cells were plated on coverslips and infected with the virus on the next day. They were incubated about 18 h, fixed with 3% paraformaldehyde, and incubated with the appropriate antibody in phosphate-buffered saline containing 0.2% gelatin (PBS-G) at room temperature for 30 min. After washing three times with PBS-G, coverslips were incubated with FITC-conjugated anti-mouse IgG (DAKO) and rhodamine-conjugated phalloidin (Molecular Probe Inc.) at room temperature for 30 min. Slides were observed under a Bio-Rad confocal microscope system (MRC 1024).


RESULTS

C-terminal Truncated Forms of PI4P5K Ialpha

C-terminal truncations of PI4P5K Ialpha were made by endonuclease digestion using unique site with BamHI (amino acids 1-456) or NcoI (amino acids 1-308) and designated 5K456S and 5K308M, respectively (Fig. 1A). Wild type and truncated constructs were tagged with the HA epitope and expressed in COS-7 cells. Control cells were infected with the vector containing lacZ insert. The size of overexpressed proteins revealed by anti-HA antibody (12CA5) were: WT, 68 kDa (Fig. 1B, lane 2); 5K456S, ~58 kDa (lane 3); and 5K308M, ~38 kDa (lane 4). Although WT and 5K456S retained PtdIns4P 5-kinase activity, 5K308M revealed little kinase activity (Fig. 1B). This was observed in several independent kinase assays and was not due to low expression levels.


Fig. 1. C-terminal truncations of PI4P5K Ialpha . A, schematic representation of C-terminal truncations. Unique enzymes (BamHI and NcoI) were used to construct. Amino acid number and a putative PIP2 binding sequence are shown. B, Western blotting and PtdIns4P 5-kinase activity. Expressed proteins were electrophoresed, transferred to nitrocellulose, and probed with anti-HA antibody (12CA5). The reactive bands were detected by ECL system (Life Technologies Inc.). Lane 1, control; lane 2, WT; lane 3, 5K456S; lane 4, 5K308M. PtdIns4P 5-kinase activity was analyzed as described (4).
[View Larger Version of this Image (29K GIF file)]


Because 12CA5 and anti-PI4P5K Ialpha antibody (4) yielded identical patterns in overexpressed cells under immunofluorescence, we used 12CA5 in subsequent investigations. Wild type PI4P5K Ialpha showed cytosolic as well as punctate distribution, and the plasma membrane also appeared to be stained (Fig. 2A). This is consistent with the results reported previously (15). Although 5K456S showed a pattern similar to WT cells, 5K308M showed diffuse but little marginal staining, which is not typical for plasma membrane localization (Fig. 2B). Between amino acids 309 and 456, there is a sequence (YRXXXXXXXSWK) similar to the putative PIP2-binding site of alpha -actinin (16). The detailed analysis of the relationship between kinase activity and the plasma membrane association will be published elsewhere.2


Fig. 2. Immunofluorescence of PI4P5K Ialpha . HA tagged PI4P5K constructs were expressed in COS-7 cells. Cells were fixed with paraformaldehyde and stained with anti-HA antibody (12CA5) followed by FITC-conjugated anti-mouse IgG. A, Wild type PI4P5K. B, 5K308M. Bar, 10 µm.
[View Larger Version of this Image (65K GIF file)]


Effect of PI4P5K Overexpression on Actin Polymerization

If PI4P5K Ialpha is an effector for actin polymerization, increased levels of PI4P5K would be expected to result in increased actin polymerization. In control cells, actin filaments were organized in parallel bundles at the bottom of the cells, and peripheral actin filaments formed lamellipodia (Fig. 3A). However, the amount of F-actin in PI4P5K WT (and 5K456S; data not shown) cells increased as shown in Fig. 3C. Typical stress fibers and lamellipodia appeared to decrease, but relatively short actin fibers were observed in random array even in aggregated fashion like "pine needles." In kinase-negative 5K308M cells, actin fibers did not show such a pattern but instead were arranged as typical stress fibers as in control cells (Fig. 3E). With double labeling of 12CA5 and rhodamine-phalloidin, we confirmed this result at single cell level even in 5K308M high expressing cells. Therefore the lack of the effect was not due to low level expression. We then overexpressed partial OCRL protein (amino acids 264-506), known to retain a PtdIns 5-phosphatase activity, in COS-7 cells (OCRL cells). This protein was found in the cytoplasm unlike the Golgi pattern of full-length OCRL (14). In contrast to the cells expressing PI4P5K, there were few actin fibers in OCRL cells (Fig. 3F). There was little change in the total amount of actin between control and PI4P5K and OCRL overexpressed cells by Western blotting (data not shown). These results strongly suggest that PI4P5K induces actin polymerization through its kinase activity by elevating levels of PIP2. These results were also observed in other cell lines (data not shown).


Fig. 3. Effect of PI4P5K Ialpha on actin polymerization. Control (A and B) and PI4P5K(WT) expressed COS-7 cells (C and D) maintained in the presence of 10% fetal bovine serum were fixed and double-stained with anti-phosphotyrosine antibody (4G10) follwed by FITC-conjugated anti-mouse IgG and rhodamine-phalloidin. 5K308M (E) or OCRL (amino acids 264-968) (F) was expressed in COS-7 (control) cells and stained with rhodamine-phalloidin. A, C, E, and F, actin fibers. B and D, phosphotyrosine staining of same cell as in A or C. The arrowheads indicate adhesion plaques. Bar, 5 µm.
[View Larger Version of this Image (92K GIF file)]


Rho has been known to regulate actin-based cytoskeleton (1, 7). The dominant negative form of RhoA, RhoN19, was made by replacing the threonine in a position analogous to codon 17 of Ras with asparagine. When RhoN19 was expressed in COS-7 cells (Fig. 4B) stress fibers decreased (Fig. 4A). We then expressed RhoN19 and PI4P5K (WT) simultaneously in COS-7 cells. Unlike RhoN19 cells, the actin fiber pattern was very similar to that in PI4P5K WT cells (Fig. 4C). Thus PI4P5K is probably located downstream from Rho, consistent with previous results (3).


Fig. 4. Coexpression of RhoN19 and PI4P5K Ialpha . RhoN19 was tagged with Myc epitope and expressed alone (A and B) or together with PI4P5K (C and D) in COS-7 cells. A, C, and D, cells were stained with rhodamine-phalloidin. B, cells were stained with anti-Myc antibody (9E10) (same cell as in A). D, actin fibers enlarged from C. Bar, 10 µm.
[View Larger Version of this Image (143K GIF file)]


Effect on Focal Adhesion

When COS-7 cells were infected with kinase active constructs (WT and 5K456S), we noticed that the degree of adhesion to the substratum decreased. This phenotype correlated with the expression levels of PI4P5K as judged by immunofluorescence. This change did not occur with expression of the kinase-negative construct (5K308M). It has been known that introduction of active Rho into Swiss 3T3 cells induces both stress fibers and focal adhesion (FA). This indicates that these two phenomena are located downstream from Rho. We stained control and PI4P5K-overexpressed cells with anti-phosphotyrosine (Tyr(P)) antibody (4G10) and anti-vinculin antibody to localize FA. Control cells showed the typical FA pattern at the end of actin stress fibers as shown in Fig. 3B (arrowheads). In PI4P5K WT cells, the Tyr(P) positive plaques were smaller, although their number was increased (Fig. 3D). Not all of the ends of actin fibers were associated with FA (Fig. 3, C and D), indicating that the increased numbers of actin fibers were not organized into typical stress fibers and did not serve to anchor the extracellular matrix effectively. This may explain why PI4P5K cells show decreased adhesion activity.


DISCUSSION

In this paper we described the effects of kinase-active and -negative forms of PI4P5K Ialpha on actin polymerization using immunofluorescence. Although several proteins that interact with Rho have been found recently (8-11), it is not clear which candidate is responsible for actin polymerization. Rho kinase is a candidate because it phosphorylates myosin phosphatase and induces a stress fiber-like pattern (17, 18). Although this indicates a pathway through myosin, it has been strongly suggested that there exists a mechanism acting directly on actin (19). Our results showed that PI4P5K plays an important role in actin polymerization. It is possible that the polymerization of actin fibers and their organization into stress fibers are distinct steps and that PI4P5K is important in the former process and Rho kinase is required in the latter process. The Rho family GTPases have been known to activate PtdIns4P 5-kinase activity (19, 20). Moreover, several recent reports have suggested that they interact with PI4P5K directly. Rac physically interacts with PI4P5K (20), and Rho binds to 68-kDa PI4P5K (21). It is possible that each member of Rho protein interacts with a different isoform of PI4P5K.

Actin polymerization is dependent on multiple ABPs. Many ABPs have been known to be regulated by PIP2, including prophillin, thymosin (22), gelsolin, actinin (23), capping protein, and vinculin (24). For example, thymosin releases free G-actin when it binds to PIP2. Binding of vinculin to actin is regulated by PIP2 (24). Rac (and/or Rho) increase free actin barbed ends through PIP2 (19). Most of these results on ABPs in relation to PIP2 were obtained in vitro because it has been difficult to prove their effects in vivo. Our system is suitable for this purpose, and the results were striking.

PI4P5K probably acts to increase PIP2 levels. PIP2 is hydrolyzed by phospholipase C (PLC) to generate inositol (1,4,5)-P3 and diacylglycerol, which are well known second messengers. Our results might include these secondary effects. However, multivalent antigen or phorbol myristate acetate causes the polymerization of actin in basophilic leukemia cells. Although multivalent antigen activates PLC, phorbol myristate acetate does not. However, in both cases, there is good correlation between F-actin levels, PtdIns kinase activity, and the increased production of PIP2 (25). Therefore, activation of PI4P5K itself does not activate PLC. Our result showing that PI4P5K-induced actin polymerization was most likely due to elevated PIP2 levels. Because OCRL overexpression decreases PIP2 levels (14), the results in OCRL cells are consistent with our model in which signals to actin are mediated by PI4P5K through elevated PIP2 levels.

FA is a multimolecular complex, and its formation and maturation are regulated by many factors including Rho, tyrosine kinases, and Src homology 2-containing proteins (26). Compared with the drastic change in actin polymerization, the effect of PI4P5K on FA was not prominent in our study. These results suggest that although integrin regulates the rate of synthesis of PIP2, FA formation needs a signal(s) other than PIP2 elevation, such as recruitment of FA proteins and sequential phosphorylation cascade.

Recent characterization of STM7 revealed that the Friedreich's ataxia gene is human PI4P5K Ialpha (27). This raises the interesting possibility that the disease is caused by a deficiency in the PtdIns pathway. Because, in addition to neurological symptoms, hypertrophic cardiomyopathy is observed in this disease, our results might be relevant to the pathogenesis. However, PIP2 itself has many biological activities other than actin polymerization. PIP2 binds many pleckstrin homology domain-containing proteins (28) and activates phospholipase D activity. Its effects need to be characterized further in our system.


FOOTNOTES

*   The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
   To whom correspondence should be addressed. Tel.: 81-3-3815-5411 (ext.3121); Fax: 81-3-5803-1874; E-mail: yshiba-tky{at}umin.u-tokyo.ac.jp.
1   The abbreviations used are: PtdIns4P, phosphatidylinositol 4-phosphate; ABPs, actin binding proteins; PtdIns, phosphatidylinositol; PIP2, phosphatidylinositol 4,5-bisphosphate; PI4P5K, phosphatidylinositol-4-phosphate 5-kinase; FITC, fluorescein isothiocyanate; HA, hemagglutinin; WT, wild type; FA, focal adhesion; PLC, phospholipase C; OCRL, oculocerebrorenal syndrome of Lowe.
2   Y. Shibasaki, H. Ishihara, N. Kizuki, T. Asano, Y. Oka, and Y. Yazaki, manuscript in preparation.

REFERENCES

  1. Hall, A. (1994) Annu. Rev. Cell Biol. 10, 31-54 [CrossRef]
  2. Janmey, P. A. (1994) Annu. Rev. Physiol. 56, 169-191 [CrossRef][Medline] [Order article via Infotrieve]
  3. Chong, L. D., Traynor-Kaplan, A., Bokoch, G. M., and Schwartz, M. A. (1994) Cell 79, 507-513 [Medline] [Order article via Infotrieve]
  4. Ishihara, H., Shibasaki, Y., Kizuki, N., Katagiri, H., Yazaki, Y., Asano, T., and Oka, Y. (1996) J. Biol. Chem. 271, 23611-23614 [Abstract/Free Full Text]
  5. Nobes, C. D., and Hall, A. (1995) Cell 81, 53-62 [Medline] [Order article via Infotrieve]
  6. Takai, Y., Sasaki, T., Tanaka, K., and Nakanishi, H. (1995) Trends Biochem. Sci. 20, 227-231 [CrossRef][Medline] [Order article via Infotrieve]
  7. Machesky, L. M., and Hall, A. (1996) Trends Cell Biol. 6, 304-310 [CrossRef]
  8. Amano, M., Mukai, H., Ono, Y., Chihara, K., Matsui, T., Hamajima, Y., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) Science 271, 648-650 [Abstract]
  9. Watanabe, G., Saito, Y., Madaule, P., Ishizaki, T., Fujisawa, K., Morii, N., Mukai, H., Ono, Y., Kakizuka, A., and Narumiya, S. (1996) Science 271, 645-648 [Abstract]
  10. Ishizaki, T., Maekawa, M., Fujisawa, K., Okawa, K., Iwamatsu, A., Fujita, A., Watanabe, N., Saito, Y., Kakizuka, A., Morii, N., and Narumiya, S. (1996) EMBO J. 15, 1885-1893 [Abstract]
  11. Matsui, T., Amano, M., Yamamoto, T., Chihara, K., Nakafuku, M., Ito, M., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) EMBO J. 15, 2208-2216 [Abstract]
  12. Boronenkov, I. V., and Anderson, R. A. (1995) J. Biol. Chem. 270, 2881-2884 [Abstract/Free Full Text]
  13. Kanegae, Y., Lee, G., Sato, Y., Tanaka, M., Nakai, M., Sakaki, T., Sugano, S., and Saito, I. (1995) Nucleic Acids Res. 23, 3816-3821 [Abstract]
  14. Zang, X., Jefferson, A. B., Auethavekiat, V., and Majerus, P. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 4853-4856 [Abstract]
  15. Jenkins, G. H., Fisette, P. L., and Anderson, R. A.. (1994) J. Biol. Chem. 269, 11547-11554 [Abstract/Free Full Text]
  16. Fukami, K., and Takenawa, T. (1996) J. Biol. Chem. 271, 2646-2650 [Abstract/Free Full Text]
  17. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) Science 273, 245-248 [Abstract]
  18. Leung, T., Chen, X-Q., Manser, E., and Lim, L. (1996) Mol. Cell. Biol. 16, 5313-5327 [Abstract]
  19. Hartwig, J. H.., Bokoch, G. M., Carpenter, C. L., Janmey, P. A., Taylor, L. A., Toker, A., and Stossel, T. P. (1995) Cell 82, 643-653 [Medline] [Order article via Infotrieve]
  20. Tolias, K., Cantley, L. C., and Carpenter, C. L. (1995) J. Biol. Chem. 270, 17656-176 [Abstract/Free Full Text]
  21. Ren, X.-D., Bokoch, G. M., Traynor-Kaplan, A., Jenkins, G. H., Anderson, R. A., and Schwartz, M. A. (1996) Mol. Biol. Cell 7, 435-442 [Abstract]
  22. Sun, H.-Q., Kwiatkowska, K., and Yin, H. L. (1995) Curr. Opin. Cell Biol. 7, 102-110 [CrossRef][Medline] [Order article via Infotrieve]
  23. Fukami, K., Endo, T., Imamura, M., and Takenawa, T. (1994) J. Biol. Chem. 269, 1518-1522 [Abstract/Free Full Text]
  24. Gilmore, A. P., and Burridge, K. (1996) Nature 381, 531-535 [CrossRef][Medline] [Order article via Infotrieve]
  25. Apgar, J. R. (1995) Mol. Biol. Cell 6, 97-108 [Abstract]
  26. Clark, E. A., and Brugge, J. S. (1995) Science 268, 233-239 [Medline] [Order article via Infotrieve]
  27. Carvajal, J. J., Pook, M. A., Santos, M., Doudney, K., Hillermann, R., Minogue, S., Williamson, R., Hsuan, J. J., and Chamberlain, S. (1996) Nat. Genet. 14, 157-162 [Medline] [Order article via Infotrieve]
  28. Harlan, J. E., Hajduk, P. J., Yoon, H. S., and Fesik, S. W. (1994) Nature 371, 168-170 [CrossRef][Medline] [Order article via Infotrieve]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.